Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lasmiditan on Heart Rate and BP with Propranolol
NCT03270644Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lasmiditan in migraine, sponsored by Eli Lilly and Company. Primary endpoint: Change From Baseline (Day 8) in Mean Hourly Heart Rate Following Propranolol Administered Alone and When Coadministered With Lasmiditan at Day 9. Started Aug 2017; status: completed.
02
Drugs
lasmiditan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03270644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03270644.